• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

甲氧苄啶/磺胺甲恶唑对弗氏红白血病细胞的作用。

The effect of trimethoprim/sulfamethoxazole on Friend erythroleukemia cells.

作者信息

Steinberg S E, Campbell C L, Rabinovitch P S, Hillman R S

出版信息

Blood. 1980 Mar;55(3):501-4.

PMID:6965592
Abstract

Cultures of Friend erythroleukemia cells were subjected to the antibiotics trimethoprim (T) and sulfamethoxazole (S) at levels equal to or below the usual therapeutic range. At T 8 microgram/ml and S 40 microgram/ml, cell growth was arrested, cells appeared megaloblastic, and the examination of cell-cycle distribution by flow microfluorimetry revealed arrest in S phase. With a tenfold reduction in drug levels (T, 08 microgram/ml; S, 4 microgram/ml) cell growth was less markedly inhibited, morphology remained megaloblastic, and S-phase block was still dramatic. A further tenfold reduction (T, 0.08 microgram/ml; S, 0.4 microgram/ml), well below effective antibacterial levels, allowed normal cell growth and morphology but DNA synthesis was still inhibited. Additions of folinic acid at 100 ng/ml averted all drug effects. Thus T/S can affect cell replication even at levels well below those usually employed and could prolong the rate of recovery of hematopoietic cells in the myelosuppressed patient.

摘要

将弗瑞德红白血病细胞培养物置于等于或低于通常治疗范围水平的抗生素甲氧苄啶(T)和磺胺甲恶唑(S)中。在T为8微克/毫升和S为40微克/毫升时,细胞生长停止,细胞呈现巨幼细胞样,通过流式微量荧光测定法检测细胞周期分布显示细胞停滞于S期。药物水平降低十倍(T为0.8微克/毫升;S为4微克/毫升)时,细胞生长受到的抑制不太明显,形态仍为巨幼细胞样,S期阻滞仍然显著。再降低十倍(T为0.08微克/毫升;S为0.4微克/毫升),远低于有效抗菌水平,细胞生长和形态恢复正常,但DNA合成仍受抑制。添加100纳克/毫升的亚叶酸可消除所有药物作用。因此,即使在远低于通常使用水平的情况下,T/S仍可影响细胞复制,并可能延长骨髓抑制患者造血细胞的恢复速度。

相似文献

1
The effect of trimethoprim/sulfamethoxazole on Friend erythroleukemia cells.甲氧苄啶/磺胺甲恶唑对弗氏红白血病细胞的作用。
Blood. 1980 Mar;55(3):501-4.
2
Effects of trimethoprim on leukaemic cells in vitro.甲氧苄啶对白血病细胞的体外作用。
Br J Haematol. 1981 Feb;47(2):221-6. doi: 10.1111/j.1365-2141.1981.tb02782.x.
3
Trimethoprim and sulphamethoxazole inhibition of haematopoiesis in vitro.甲氧苄啶和磺胺甲恶唑对体外造血的抑制作用。
Br J Haematol. 1978 Nov;40(3):363-7. doi: 10.1111/j.1365-2141.1978.tb05807.x.
4
Susceptibility of obligate anaerobes to trimethoprim-sulfamethoxazole.专性厌氧菌对甲氧苄啶-磺胺甲恶唑的敏感性。
J Am Vet Med Assoc. 1986 Jan 1;188(1):46-8.
5
In vitro additive effect of nitrofurantoin combined with trimethoprim-sulfamethoxazole against Serratia marcescens.呋喃妥因联合甲氧苄啶-磺胺甲恶唑对粘质沙雷氏菌的体外相加作用。
Chemotherapy. 1979;25(3):140-6. doi: 10.1159/000237833.
6
Studies of the effects of trimethoprim and sulfamethoxazole on human granulopoiesis.
Am J Hematol. 1986 Sep;23(1):1-7. doi: 10.1002/ajh.2830230102.
7
Reduction in p53 synthesis during differentiation of Friend-erythroleukemia cells. Correlation with the commitment to terminal cell division.弗瑞德红白血病细胞分化过程中p53合成的减少。与终末细胞分裂的关联。
FEBS Lett. 1983 Oct 17;162(2):384-9. doi: 10.1016/0014-5793(83)80792-3.
8
Beneficial effect of sulfamethoxazole and trimethoprim on accelerated coagulation.磺胺甲恶唑和甲氧苄啶对加速凝血的有益作用。
Agents Actions. 1987 Aug;21(3-4):260-1. doi: 10.1007/BF01966484.
9
Antibiotic sensitivity of enteropathogenic Escherichia coli to mecillinam, trimethoprim-sulfamethoxazole and other antibiotics.致病性大肠杆菌对美西林、甲氧苄啶-磺胺甲恶唑及其他抗生素的敏感性
Acta Pathol Microbiol Scand B. 1980 Oct;88(5):265-8. doi: 10.1111/j.1699-0463.1980.tb02639.x.
10
Influence of trimethoprim and sulfamethoxazole on the synthesis, expression, and function of type 1 fimbriae of Escherichia coli.甲氧苄啶和磺胺甲恶唑对大肠杆菌1型菌毛合成、表达及功能的影响。
J Infect Dis. 1986 Sep;154(3):490-6. doi: 10.1093/infdis/154.3.490.

引用本文的文献

1
Effect of folinic acid on the capacity of trimethoprim-sulfamethoxazole to prevent and treat Pneumocystis carinii pneumonia in rats.亚叶酸对甲氧苄啶-磺胺甲恶唑预防和治疗大鼠卡氏肺孢子虫肺炎能力的影响。
Antimicrob Agents Chemother. 1986 Feb;29(2):327-9. doi: 10.1128/AAC.29.2.327.